{
  "timestamp": "2025-12-17T11:52:55.904986",
  "data": {
    "trials": {
      "summary": {
        "active": 3,
        "completed": 2,
        "phase_distribution": {
          "Observational": 1,
          "Phase 1": 0,
          "Phase 2": 2,
          "Phase 3": 1,
          "Phase 4": 0
        }
      },
      "details": [
        {
          "trial_id": "NCT04610541",
          "title": "Open-label Study to Assess the Safety of REMdesivir-HU as Eligible Novel therapY for Moderate and Severe Covid-19 Patients",
          "status": "Active",
          "phase": "Phase 3",
          "sponsor": "University of Pecs",
          "locations": [
            "Hungary"
          ],
          "start_date": "2020-10-12",
          "end_date": "2021-11-30"
        },
        {
          "trial_id": "NCT04647695",
          "title": "An Open-label Randomized Controlled Trial on Interferon \u03b2-1b and Remdesivir Combination Versus Remdesivir as Treatment for COVID-19 Infection",
          "status": "Active",
          "phase": "Phase 2",
          "sponsor": "The University of Hong Kong",
          "locations": [
            "Hong Kong"
          ],
          "start_date": "2020-11-20",
          "end_date": "2021-09-30"
        },
        {
          "trial_id": "NCT04345419",
          "title": "Remdesivir in COVID-19 Treatment: A Randomised Trial",
          "status": "Completed",
          "phase": "Phase 2",
          "sponsor": "Tanta University",
          "locations": [
            "Egypt"
          ],
          "start_date": "2020-06-16",
          "end_date": "2020-12-01"
        },
        {
          "trial_id": "NCT04582266",
          "title": "Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the United States",
          "status": "Completed",
          "phase": "Observational",
          "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)",
          "locations": [
            "United States"
          ],
          "start_date": "2021-03-31",
          "end_date": "2022-04-13"
        },
        {
          "trial_id": "NCT04560231",
          "title": "Is Remdesivir a Possible Therapeutic Option for SARS-CoV-2 : An Interventional Study",
          "status": "Active",
          "phase": "EARLY_Phase 1",
          "sponsor": "Lahore General Hospital",
          "locations": [
            "Pakistan"
          ],
          "start_date": "2020-06-01",
          "end_date": "2020-11-30"
        }
      ],
      "notes": "Parsed deterministically from ClinicalTrials.gov"
    }
  }
}